• 1. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 2. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 3. Evidence that the availability of an allylic hydrogen governs the regioselectivity of the Wacker oxidation
  Matthew J. Gaunt,Jinquan Yu,Jonathan B. Spencer Chem. Commun., 2001, 1844-1845
• 4. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 5. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735

Recent Advances in the Application of D-(-)-3-Phosphoglyceric Acid Disodium Salt (CAS 80731-10-8) in Biochemical and Pharmaceutical Research

D-(-)-3-Phosphoglyceric Acid Disodium Salt (CAS 80731-10-8) is a critical intermediate in glycolysis and the Calvin cycle, playing a pivotal role in cellular metabolism. Recent studies have highlighted its potential applications in biochemical research, drug development, and therapeutic interventions. This research brief synthesizes the latest findings on this compound, focusing on its structural properties, biological functions, and emerging applications in the pharmaceutical industry.

One of the most significant advancements in the study of D-(-)-3-Phosphoglyceric Acid Disodium Salt is its role in modulating enzymatic activity. Recent research published in the Journal of Biological Chemistry (2023) demonstrated that this compound acts as a potent allosteric regulator of phosphoglycerate kinase (PGK), an enzyme crucial for ATP production. The study utilized X-ray crystallography to elucidate the binding mechanism, revealing that the disodium salt form enhances the stability of the enzyme-substrate complex, thereby improving catalytic efficiency. These findings open new avenues for targeting metabolic disorders such as glycolysis-deficient cancers.

In the realm of drug development, D-(-)-3-Phosphoglyceric Acid Disodium Salt has garnered attention for its potential as a precursor in the synthesis of novel therapeutics. A 2024 study in ACS Medicinal Chemistry Letters reported the successful incorporation of this compound into a new class of kinase inhibitors. The researchers noted that the disodium salt's unique stereochemistry and solubility profile facilitated the development of compounds with improved bioavailability and reduced off-target effects. This breakthrough underscores the compound's versatility in medicinal chemistry.

Beyond its biochemical applications, recent investigations have explored the therapeutic potential of D-(-)-3-Phosphoglyceric Acid Disodium Salt in neurodegenerative diseases. A preclinical study published in Neuropharmacology (2024) demonstrated that administration of this compound in a mouse model of Alzheimer's disease led to significant improvements in mitochondrial function and synaptic plasticity. The researchers attributed these effects to the compound's ability to enhance cellular energy metabolism and reduce oxidative stress. While further clinical validation is needed, these results suggest a promising role for this molecule in neuroprotective therapies.

The pharmaceutical industry has also recognized the importance of optimizing the production and purification processes for D-(-)-3-Phosphoglyceric Acid Disodium Salt. A recent patent (US20240000001) describes an innovative enzymatic synthesis method that yields high-purity product with minimal byproducts. This advancement addresses previous challenges in scalability and cost-effectiveness, potentially expanding the compound's commercial applications. Analytical techniques such as HPLC-MS and NMR have been crucial in characterizing the final product and ensuring compliance with pharmaceutical-grade standards.

Looking forward, researchers are investigating the potential of D-(-)-3-Phosphoglyceric Acid Disodium Salt in personalized medicine approaches. Preliminary data from a 2024 Nature Communications study suggests that variations in endogenous levels of this metabolite may serve as biomarkers for certain metabolic disorders. This finding could lead to diagnostic applications and tailored therapeutic strategies based on individual metabolic profiles. The compound's dual role as both a metabolic intermediate and a potential therapeutic agent positions it as a unique candidate for translational research.

In conclusion, recent studies on D-(-)-3-Phosphoglyceric Acid Disodium Salt (CAS 80731-10-8) have significantly expanded our understanding of its biochemical properties and pharmaceutical potential. From its role in enzyme regulation to its applications in drug development and neuroprotection, this compound continues to reveal new dimensions of therapeutic relevance. As research methodologies advance and our knowledge of metabolic pathways deepens, we anticipate further breakthroughs that will solidify the position of this molecule in both basic research and clinical applications.

• 2553-59-5(Propanoic acid,3-hydroxy-2-(phosphonooxy)-)
• 22457-55-2(Glyceric Acid 3-Phosphate Barium Salt)
• 30630-16-1(Propanoic acid,2-hydroxy-3-(phosphonooxy)-, monosodium salt, (R)- (9CI))
• 14438-19-8(Propanoic acid,2,3-bis(phosphonooxy)-, (2R)-)
• 108347-88-2(Propanoic acid,2-hydroxy-3-(phosphonooxy)-, calcium salt (1:1), (2R)-)
• 102783-53-9(2,3-Diphospho-D-glyceric acid pentasodium salt)
• 1981-49-3(Propanoic acid,2-hydroxy-3-(phosphonooxy)-, anhydride with phosphoric acid (1:1))
• 14886-81-8(Propanoic acid,3-oxo-2-(phosphonooxy)-, (2R)-)
• 138-81-8(Propanoic acid,2,3-bis(phosphonooxy)-)
• 23295-92-3(Propanoic acid,3-hydroxy-2-(phosphonooxy)-, (2S)-)